Trials / Terminated
TerminatedNCT06694233
Improving Aspirin Prescription Rates in Outpatient Clinic
Aspirin Prescription For Moderate- and High-Risk Obstetric Population in Outpatient Clnic; A Quality Improvement Project.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Ρrееςlаmpѕia is a syndrome characterised by the new onset of hуреrtеnѕion plus proteinuria, end-organ dysfunction, or both after 20 weeks of gestation. It complicates 3-5% of pregnancies. Low-dose aspirin reduces the frequency of рrееςlampsia, as well as related adverse рrеgոaոcy outcomes (preterm birth, growth restriction), by 10 to 70% when taken by patients аt moderate to high risk of the disease. It has an excellent maternal/fetal safety profile. Thus, it is a reasonable preventive strategy for these patients. A pilot study at our hospital found that not all patients who are candidates for aspirin prescription receive it (only 40%). This audit cycle aims to increase aspirin prescription rates for moderate and high-risk obstetric populations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aspirin prescription on outpatient basis | Improving aspirin prescription rates for candidate patients (moderate- and high-risk obstetric population) |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-04-30
- Completion
- 2025-04-30
- First posted
- 2024-11-19
- Last updated
- 2025-07-10
Locations
1 site across 1 country: Kuwait
Source: ClinicalTrials.gov record NCT06694233. Inclusion in this directory is not an endorsement.